162 related articles for article (PubMed ID: 33468764)
1. [Two Cases of Resectable Liver Metastasis from Colorectal Cancer with Pathological Complete Response after Neoadjuvant Chemotherapy].
Sato H; Ii T; Rikiyama N; Noguchi A; Aoki Y; Sato J; Kikuchi D; Yamanami H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1954-1956. PubMed ID: 33468764
[TBL] [Abstract][Full Text] [Related]
2. [Two Cases of Unresectable Advanced Rectal Cancer with a Long-Term Survival for Which Pathological Complete Response Was Achieved through Neoadjuvant Effective Chemotherapy].
Gonda K; Tachiya Y; Hatakeyama Y; Shibata M; Kono K; Rokkaku Y
Gan To Kagaku Ryoho; 2017 Oct; 44(10):944-946. PubMed ID: 29066704
[TBL] [Abstract][Full Text] [Related]
3. [Two Cases of Locally Advanced Colorectal Cancer Involving Pathological Complete Response after Chemotherapy].
Rikiyama N; Sato H; Hotchi S; Goh K; Sato A; Akishige N; Noguchi A; Aoki Y; Sato J; Kikuchi D; Ii T; Yamanami H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1761-1763. PubMed ID: 35046322
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
Takatsuki M; Tokunaga S; Uchida S; Sakoda M; Shirabe K; Beppu T; Emi Y; Oki E; Ueno S; Eguchi S; Akagi Y; Ogata Y; Baba H; Natsugoe S; Maehara Y;
Eur J Surg Oncol; 2016 Feb; 42(2):184-9. PubMed ID: 26683263
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Liver Metastasis from Colorectal Cancer That Showed a Pathological Complete Response to mFOLFOX6 plus Cetuximab].
Konishi K; Ikenaga M; Ohta K; Nakashima S; Nakagawa T; Endo S; Yamada T; Chihara T; Nishijima J
Gan To Kagaku Ryoho; 2016 Aug; 43(8):1003-7. PubMed ID: 27539045
[TBL] [Abstract][Full Text] [Related]
6. [Three Cases of Stage Ⅳ Low Rectal Cancer with Lateral Pelvic Lymph Node Metastasis].
Tamura H; Shimada Y; Yagi R; Tajima Y; Okamura T; Nakano M; Ishikawa T; Sakata J; Kobayashi T; Kameyama H; Kosugi S; Wakai T; Nogami H; Maruyama S; Takii Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2303-5. PubMed ID: 26805345
[TBL] [Abstract][Full Text] [Related]
7. [Two Cases of Metastatic Rectal Cancer Patients Who Received Chemotherapy with FOLFOXIRI plus Bevacizumab].
Nishii T; Uchima Y; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Aomatsu N; Iwauchi T; Morimoto J; Nakazawa K; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1705-1707. PubMed ID: 28133105
[TBL] [Abstract][Full Text] [Related]
8. [Pathological Complete Response in a Case of Multiple Liver Metastases from Rectal Cancer Treated with XELOX plus Bevacizumab(Bev)Therapy].
Noura S; Shuto T; Muratsu A; Yoshida Y; Yasuyama A; Matsumura T; Koga C; Kameda C; Murakami M; Kawabata R; Hirota M; Yoshikawa M; Shimizu J; Hasegawa J; Miwa H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1742-1744. PubMed ID: 28133117
[TBL] [Abstract][Full Text] [Related]
9. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
10. [A case or resection of synchronous multiple liver metastases from rectal cancer after FOLFOX4 therapy].
Deguchi Y; Endo S; Tanaka J; Kasugai H; Ikehara K; Hidaka E; Hashimoto M; Ishida F; Kudo SE
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1159-62. PubMed ID: 20567128
[TBL] [Abstract][Full Text] [Related]
11. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
[TBL] [Abstract][Full Text] [Related]
12. [A case with liver resection of metastasis from rectal cancer after FOLFOX4+bevacizumab treatment].
Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kure N; Kojima H
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1761-3. PubMed ID: 18931584
[TBL] [Abstract][Full Text] [Related]
13. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
[TBL] [Abstract][Full Text] [Related]
14. [A Case of a Patient with Rectum Cancer with Multiple Metastases, Who Was Able to Undergo Conversion Therapy Using Alternating mFOLFOX6 and FOLFIRI Regimens in Combination with Alternating Cetuximab and Bevacizumab].
O'hara H; Yamamoto H
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1669-1672. PubMed ID: 30449861
[TBL] [Abstract][Full Text] [Related]
15. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Advanced Rectal Cancer Resected Successfully after Induction Chemotherapy with Modified FOLFOX6 plus Panitumumab].
Yukawa Y; Uchima Y; Kawamura M; Takeda O; Hanno H; Takayanagi S; Hirooka T; Dozaiku T; Hirooka T; Aomatsu N; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Takeuchi K
Gan To Kagaku Ryoho; 2016 May; 43(5):641-4. PubMed ID: 27210100
[TBL] [Abstract][Full Text] [Related]
17. [A case of resected rectal cancer with hepatic node and multiple liver metastases effectively treated by preoperative modified FOLFOX6 and sLV5FU2 chemotherapy].
Seshimo K; Oishi M; Toshima T; Ikeda H; Kato H; Yamamura M; Kodera M; Yamashita Y; Tanaka N; Fujita H; Shibagaki K; Taniguchi H; Matsuki T; Kobayashi K; Takita K
Gan To Kagaku Ryoho; 2012 Mar; 39(3):477-80. PubMed ID: 22421784
[TBL] [Abstract][Full Text] [Related]
18. [Laparoscopic Abdominoperineal Resection Following Intensive Chemotherapy for Stage Ⅳ Rectal Cancer with Unresectable Metastases].
Nakatsukasa R; Hata T; Hayashi N; Urabe S; Hayashi K; Nakagawa T; Michiura T; Yamabe K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2260-2262. PubMed ID: 33468927
[TBL] [Abstract][Full Text] [Related]
19. [Two Cases of Advanced Colorectal Cancer Achieving Complete Response by FOLFOXIRI plus Bevacizumab-A Case Report].
Nemoto T; Endo S; Isohata N; Takayanagi D; Nemoto D; Aizawa M; Utano K; Togashi K; Oshibe I; Soeta N; Saito T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2410-2412. PubMed ID: 32156948
[TBL] [Abstract][Full Text] [Related]
20. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
